User fee negotiations in US offer hope for improvements to interactive review for medical device submissions
This article was originally published in RAJ Devices
Executive Summary
Kristin M Zielinski discusses the shortfalls of the Food and Drug Administration's interactive review programme and the improvements "on the table".